Understanding cancer disease status and what it means for intensivists

A thorough understanding of oncological disease status is crucial for managing critically ill patients with cancer. The cancer trajectory predisposes patients to the type of critical illness they could develop and shapes the likelihood of reversibility and the chance for meaningful recovery, including continuation of therapy. This review outlines how disease status-whether new diagnosis, remission, stable disease, or progression-directly impacts differential diagnosis and treatment goals in the intensive care unit (ICU). Prognosis can be subdivided into (1) the comorbid cancer condition and (2) the acute critical care condition. Factors that impact prognosis may be similar including patient frailty, extent of organ failure, and tumor-related factors. While ICU survival remains an important patient-centered outcome, long-term outcomes such as return to treatment and acceptable quality of life have become increasingly important as ICU survival has improved over the past decades. Clear communication about patient values helps align care with realistic goals and avoid disproportionate ICU treatment. However, a critical element of establishing realistic goals includes a thorough understanding of the oncologic disease status. Close collaboration between intensivists and oncologists improves prognostication, treatment planning, and advance care discussions. Early recognition of high-risk patients and clear escalation or limitation pathways help ensure timely ICU transfer when needed. After ICU discharge, coordinated follow-up and rehabilitation support recovery and candidacy for further oncological treatment. An integrated, goal-directed approach enables tailored care for this complex patient group and supports shared decision-making throughout the continuum of cancer care.